Are there any generic versions of Pralsetinib?

Pralsetinib (Pralsetinib) currently has no generic drugs on the market. The U.S. Food and Drug Administration (FDA) approved platinib for the treatment of three indications: adult patients with metastasis-positive non-small cell lung cancer who have been detected in an FDA-approved study, adult and pediatric patients 12 years and older with advanced or metastatic RET MTC mutations, and adult and pediatric patients 12 years and older with advanced or metastatic thyroid-positive cancer who require systemic therapy and are refractory to treatment with radioactive iodine (if radioactive iodine is appropriate). Platinibis not approved for other indications in China, the United States, or Europe.